Epidemiologist stresses COVID-19 pathophysiologic research
chinadaily.com.cn |
Updated: 2020-03-19 08:00
Share
Share - WeChat
More research should be done on the overreaction of the immune response in COVID-19 disease, said Zhong Nanshan, China's leading epidemic control expert, in a recent video talk.
Zhong also noted that once the patients deteriorate, the survival rate is pretty low, as some of the pathophysiologic characteristics are different from usual cases of ARDS, or acute respiratory distress syndrome.
Zhong shared China's experience in the fight against the coronavirus with Dr. Anita Simonds, the president-elect of the European Respiratory Society, in an online conversation earlier this month.
- 8 held after children found with abnormal blood lead levels
- Country's high-speed rail network wins intl praise
- Thousands of PLA personnel deployed to flood-hit Rongjiang
- China's largest weapons manufacturer appoints new chairman
- Greater Bay Area rail passenger flows surge
- Shanghai exhibit hails role of Flying Tigers in liberating China
